iPSC/ESC

The latest induced, embryonic, and other pluripotent stem cell news.

BlueRock Therapeutics advances to Phase III trial for Parkinson’s disease iPSC therapy

Phase III exPDite-2 trial follows completion and discussion of Phase I trial data with US FDA under Regenerative Medicine Advanced Therapy (RMAT) designation  exPDite-2 is a randomized, sham surgery-controlled double-blind trial assessing...

iPSC/ESC, Neurology | March 2, 2025

Japan says iPSCs ready for mainstream adoption, in final approval stages to cover stem cell therapy for retinas under national health insurance

Japan is reportedly in the final stages of approving the first induced pluripotent stem cell (iPS cell) treatment for inclusion in its national healthcare system. Approval would position Japan among the first...

iPSC/ESC, Ophthalmology | February 27, 2025